Scientists have created a face mask that can detect common respiratory viruses, including influenza and the coronavirus, in the air in droplets or aerosols.
A Rutgers infectious disease expert explains why getting the annual flu shot is important to individual and public health
The Center for Disease Control’s National Center for Immunization and Respiratory Diseases has awarded University Hospitals of Cleveland a sizable grant to support its assignment as a study site in the United States Flu Vaccine Effectiveness Network.
Sarah Knight, MD, Primary Care, Internal Medicine at Ochsner Health shares tips for staying healthy this flu season.
Many respiratory infections, such as influenza or COVID-19 add significant stress to cells and organs, which can lead to acute respiratory distress syndrome (ARDS), which itself can eventually cause death in aged or sensitive individuals.
Infectious Disease experts at Ochsner Health in New Orleans reveal the top 10 myths about the flu and flu vaccines in 2022.
A new universal flu vaccine protects against diverse variants of both influenza A and B viruses in mice, according to a new study by researchers in the Institute for Biomedical Sciences at Georgia State University.
A new poll shows that 61% of people over 50 who have already gotten at least one dose of COVID-19 vaccine are very likely to roll up their sleeves this fall to get an updated booster shot once they become available. That percentage might increase if health care providers specifically recommend the updated vaccine to their patients, the poll suggests.
JMIR Publications recently published "Diagnostic Accuracy of an At-Home, Rapid Self-test for Influenza: Prospective Comparative Accuracy Study" in JMIR Public Health and Surveillance which reported that rapid diagnostic tests (RDTs) for influenza used by individuals at home could potentially expand access to testing and reduce the impact of influenza on health systems. Improving access to testing could lead to earlier diagnosis following symptom onset, allowing more rapid interventions for those who test positive, including behavioral changes to minimize spread.
The latest research news in Climate Science on Newswise.
A new universal flu vaccine constructed with key parts of the influenza virus offers broad cross protection against different strains and subtypes of influenza A viruses in young and aged populations, according to a new study by researchers in the Institute for Biomedical Sciences at Georgia State University.
In ACS Infectious Diseases, scientists now report that apratoxin S4, an anticancer drug candidate that targets a human protein, can interfere with the replication of many viruses, including SARS-CoV-2 and influenza A, offering a possible pan-viral therapy.
People who received at least one influenza vaccine were 40% less likely than their non-vaccinated peers to develop Alzheimer’s disease over the course of four years, according to a new study from UTHealth Houston.
A collaborative study from UT Southwestern scientists has identified a new function for a protein called TAO2 that appears to be key to inhibiting replication of the influenza virus, which sickens millions of individuals worldwide each year and kills hundreds of thousands. The findings were published in PNAS.
Researchers at UH Rainbow published new findings that COVID-19 is not equivalent to flu infection for children. Among 66 pediatric ICUs in the US, the number admitted each quarter with COVID-19 or MIS-C during the first 15 months of the pandemic was twice as high as that for flu pre-pandemic.
The influenza A virus, which is responsible for seasonal flu outbreaks, is also the only influenza virus that has previously caused flu pandemics.
A new study from Tufts University and other collaborators takes a data-driven look at influenza viruses circulating among different groups of birds and characterizes which types of birds are involved in spreading the virus. This paper publishes at a time when a highly pathogenic strain of avian influenza has been spreading across North America.
Researchers have shown for the first time in mice that heart problems seen in some of the sickest flu patients are caused by direct influenza infection of cardiac cells.
Ted Ross, Ph.D., has been appointed Global Director of Vaccine Development at Cleveland Clinic. In this newly created role, he will lead the development of novel vaccine platforms for a variety of infectious diseases, including influenza, HIV and COVID-19. A highly renowned scientist with expertise in virology, vaccines, immunology and microbiology, Dr. Ross’ research focuses on the design of new vaccines and the implementation of new vaccine trials.
The two-year anniversary of the COVID-19 pandemic came and went without much fanfare, thanks to a lull in cases and deaths, and the start of a war in Ukraine that has grabbed the world’s attention. But for medical historians who led an exhaustive study of the 1918 influenza pandemic, the recent milestone offers a chance to look back on the parallels, and differences, in how the nation responded to both massive infectious threats.
A new study set out to better understand the impacts and trade-offs policymakers must consider when addressing modern infectious diseases and their macroeconomic repercussions.
.jpg&width=400&height=400)
Researchers at McMaster University have found that children who receive years of season-specific flu vaccines develop antibodies that also provide broader protection against new strains, including those capable of causing pandemics.
Queen’s University Belfast will lead a new £1.6m collaborative project to rapidly identify new treatments for COVID-19.
发热、胃部不适、腹泻、咽喉疼痛、寒战、咳嗽、打喷嚏和头痛都会让您感到痛苦。而在您感到不适时往往很难确切知道问题出在哪里，也不知道怎么让自己好起来。随着流感季节临近，我们正好借此机会来探讨什么是流感症状和非流感症状。
يمكن أن تجعلك الحمى واضطراب المعدة والإسهال والتهاب الحلق والقشعريرة والسعال والعطاس والصداع في حال بائسة. وعندما لا تكون على ما يرام، قد يكون من الصعب أحيانًا معرفة المشكلة بالضبط، وكيف يمكنك مساعدة نفسك على الشعور بالتحسن. مع اقتراب موسم الإنفلونزا، فالوقت مناسب الآن للنظر في أعراض الإنفلونزا- وما ليس بسبب الإنفلونزا.
Mayo Clinic experts are available to offer commentary and perspective on the "new normal" as COVID-19 transitions to an endemic disease. Among Mayo Clinic experts who are available
As the first cases of flu are reported in Los Angeles this season, public health experts are urging anyone who isn't already vaccinated to get the flu shot. It's the best protection against the flu, which could pummel the U.S. this winter after nearly disappearing last year.
Vaccine hesitancy is considered one of the top 10 threats to public health by the World Health Organization.
High levels of European ancestry are associated with an increase in type I interferon pathway activity in early infection
For the second straight year, flu season is emerging against the backdrop of the COVID-19 pandemic. While the number of flu cases was relatively low last year, experts at Johns Hopkins Medicine say that this year, it could be much higher.
With two viruses threatening to make older adults sick this winter, a new poll shows most people over 50 have gotten protected by vaccines against both influenza and coronavirus, or plan to. And a majority of those who have gotten the COVID-19 vaccine plan to get an additional dose. But the poll also reveals major differences in vaccine attitudes between older adults, including those of different political leanings.
As flu season approaches, public health officials are urging people to get a flu shot. Many communities of color are at higher risk of death from both influenza and COVID-19, says DePaul University health sciences faculty member Julia Lippert, and outcomes vary across the largest cities in the United States.
Lateral flow assays often called ‘dipsticks’ have been a popular point-of-care testing platform for decades (think, pregnancy tests, glucose tests, even coronavirus tests). But they have limitations. A team of researchers is overcoming those limitations with development of a flow control technology, turning these simple tests into complex biomedical assays.
Although the influenza virus varies a lot from year to year, the flu usually contributes to approximately 1000 deaths a year in Norway.
The members of the Critical Care Societies Collaborative, which includes the American Association of Critical-Care Nurses, American College of Chest Physicians, American Thoracic Society, and Society of Critical Care Medicine, strongly urge individuals to get vaccinated against the COVID-19 virus and to receive their influenza (flu) immunizations for the upcoming flu season.
“Twindemic” is a term that has not yet been in the headlines but is likely to become part of our lexicon as the summer progresses.
Patients who have cardiovascular disease are at increased risk of serious complications from the flu, according to a new study by Houston Methodist physician researchers published in the Journal of the American Heart Association. The study found that not only are traditional flu-related outcomes worse among some patients with CVD, but infection in those patients also is associated with an increased risk of cardiovascular events and both CV-related mortality and mortality from all causes.
A cell-based influenza vaccine has effectively provided protection against the flu in children and adolescents, according to a new study.
By creating the Universal Influenza-like Transmission (UnIT) score, which leverages data about past flu seasons, researchers at the University of Chicago have produced a new model of COVID-19 incidence that outperforms all other prediction models on average over the pandemic timeline so far.
Study may have implications for other vaccinations, including COVID-19 vaccine.
A meme widely shared on Facebook shows a picture of Bill Gates holding a needle with his face painted like the supervillain “The Joker” and says, “Do you honestly believe that in 70 years of research and development we have a 40% effective flu shot but in 10 months a 95% effective Rona shot?” Comparing the efficacy of the vaccines suggest they both inoculate patients from the same virus. The viruses are different, and comparing the efficacy of the vaccines is misleading.
Michaela Gack, Ph.D., scientific director of Cleveland Clinic’s Florida Research and Innovation Center, has received a National Institutes of Health (NIH) Director’s Pioneer Award to support her research toward the development of broad-spectrum antiviral drugs. The prestigious grant is part of NIH’s High-Risk, High-Reward Research Program, which funds highly innovative research with the potential for broad impact, and will provide $5.6 million over five years.
The flu seemed to vanish in 2020 as safety measures meant to stop the spread of COVID-19 also worked against the influenza virus. But with some precautions lifted amid widespread vaccination, what will it mean for this year's flu season?
UNLV scientists are partnering with 20 other states to keep watch for flu strains that are cropping up in wastewater in communities across the country to better target future influenza vaccines and make them more effective.
UAB’s Jessica Grayson, M.D., clears the confusion on how to tell COVID-19 from other respiratory illnesses.
Researchers who studied the patterns of high-risk individuals’ influenza vaccinations find that this at-risk group is more likely to obtain vaccinations from a trusted doctor’s office or primary care clinic, rather than state- or community-affiliated centers.
The U.S. Centers for Disease Control and Prevention has awarded $15.88 million to the Wayne State University School of Medicine’s Department of Emergency Medicine to be the epicenter of a national study on viral infections that present in emergency departments across the county.
Flu Season Returns Amid COVID-19 Pandemic: Johns Hopkins Medicine Experts Available
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right
